Whole-Body Positron Emission Tomographic Scanning in Patients with Adrenal Cortical Carcinoma: Comparison with Conventional Imaging Procedures

Clinical Nuclear Medicine

Volumn 28, Issue 6, 2003, Pages 494-497

  Ahmed, Mohammed ^a   Al Sugair, Abdulaziz ^a   Alarifi, Abdullah ^a   Almahfouz, Abdulraof ^a   Al Sobhi, Saif ^a  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

Author keywords

Adrenal Cortical Carcinoma; F 18 Fluorodeoxyglucose; Positron Emission Tomography

Indexed keywords

FLUORODEOXYGLUCOSE; DIAGNOSTIC AGENT; FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT;

ADRENAL CORTEX CARCINOMA; ADULT; ARTICLE; BONE SCINTISCANNING; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CUSHING SYNDROME; DISEASE COURSE; ECHOGRAPHY; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; ADRENAL CORTEX TUMOR; COMPARATIVE STUDY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; SCINTISCANNING;

ADRENAL CORTEX NEOPLASMS; ADRENOCORTICAL CARCINOMA; ADULT; CUSHING SYNDROME; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 85047693352     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.RLU.0000067512.53644.FB     Document Type: Article

References (10)

1. Huvos AG, Hadju SI, Brasfield RD, et al: Adrenal cortical carcinoma: clinicopathologic study of 34 cases. Cancer 25:354, 1970.
2. Hajjar RA, Hickey RC, Samaan NA: Adrenal cortical carcinoma. Cancer 35:549, 1975.
3. Schteinghart DE: Cushing syndrome. In: Becker KL, ed. Principles and Practice of Endocrinology and Metabolism. Philadelphia: JB Lippincott, 2001, pp 723-37.
4. Lee MJ, Hahn PF, Papanicolaou N, et al: Benign and malignant adrenal masses: CT distinction with attenuation coefficients, size, and observer analysis. Radiology 179:415, 1991.
5. Schlund JF, Kenney PJ, Brown ED, et al: Adrenocortical carcinoma: MR imaging appearance with current techniques. J Magn Reson Imaging 5:171, 1995.
6. Kunishima S, Taniguchi H, Yamaguchi A, et al: Evaluation of abdominal tumors with [F- 18] fluorodeoxyglucose positron emission tomography. Clin Pos Imag 3:91, 2000.
7. Strauss LG, Conti PS: The applications of PET in clinical oncology. J Nucl Med 32:623, 1991.
8. Mijin Y, Woojin K, Naheel A, et al: F-FDG PET in characterizing adrenal lesions detected on CT or MRI. J Nucl Med 42:1795, 2001.
9. Maurea S, Mainolfi C, Bazzicalupo L, et al: Imaging of adrenal tumors using FDG PET: comparison of benign and malignant lesions. AJR Am J Roentgenol 173:25, 1999.
10. Boland GW, Goldberg MA, Lee MJ, et al: Indeterminate adrenal mass in patients with cancer: evaluation at PET with 2-[F-18]-fluoro-2-deoxy-D-glucose. Radiology 194:131, 1995.